Emergent BioSolutions, Inc.

62
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29089Q1058
USD
8.05
-0.14 (-1.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
742.00
1,043.00
1,049.00
1,117.00
1,773.00
1,555.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
742.00
1,043.00
1,049.00
1,117.00
1,773.00
1,555.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
59.00
71.00
96.00
37.00
28.00
27.00
General and Administration Expenses
186.00
298.00
356.00
337.00
348.00
303.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
632.00
1,102.00
1,221.00
1,276.00
1,387.00
1,060.00
Operating Profit (PBDIT) excl Other Income
110.00
-58.00
-172.00
-158.00
386.00
494.00
Other Income
54.00
36.00
92.00
-11.00
-9.00
4.00
Operating Profit (PBDIT)
262.00
90.00
49.00
-21.00
502.00
613.00
Interest
59.00
71.00
96.00
37.00
28.00
27.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
98.00
112.00
129.00
148.00
126.00
114.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
82.00
-142.00
-731.00
-219.00
303.00
407.00
Provision for Tax
30.00
47.00
29.00
-7.00
83.00
102.00
Profit After Tax
52.00
-190.00
-760.00
-211.00
219.00
305.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.93
-3.60
-14.85
-4.22
4.06
5.67
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -28.81% vs -0.54% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 288.70% vs 66.05% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -16.48% vs -26.65% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 127.60% vs 74.94% in Dec 2024

Compare Profit and Loss Results of Emergent BioSolutions, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
742.00
2.00
740.00
37,000.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
742.00
2.00
740.00
37,000.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
59.00
5.00
54.00
1,080.00%
General and Administration Expenses
186.00
31.00
155.00
500.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
632.00
101.00
531.00
525.74%
Operating Profit (PBDIT) excl Other Income
110.00
-99.00
209.00
211.11%
Other Income
54.00
10.00
44.00
440.00%
Operating Profit (PBDIT)
262.00
-87.00
349.00
401.15%
Interest
59.00
5.00
54.00
1,080.00%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
98.00
1.00
97.00
9,700.00%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
82.00
-94.00
176.00
187.23%
Provision for Tax
30.00
0.00
30.00
0%
Profit After Tax
52.00
-94.00
146.00
155.32%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.9277
-1.4463
2.37
164.14%
Profit And Loss - Net Sales
Net Sales 742.90 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -28.81% vs -0.54% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 110.20 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 288.70% vs 66.05% in Dec 2024

Profit And Loss - Interest
Interest 59.30 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -16.48% vs -26.65% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 52.60 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 127.60% vs 74.94% in Dec 2024